# OnCo record dako-er-pr-ihc (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/dako-er-pr-ihc/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "dako-er-pr-ihc" ;
  schema:name "Agilent (Dako) ER and PR immunohistochemistry: ER/PR pharmDx, ER clone EP1, PR clones PgR 636 and PgR 1294"@en ;
  schema:alternateName "ER/PR pharmDx"@en, "Dako ER EP1"@en, "Dako PgR 636"@en, "Dako PgR 1294"@en, "FLEX ER EP1"@en, "FLEX PgR 636"@en, "Dako ER/PR" ;
  schema:description "Dako's antibodies and kit for staining the oestrogen and progesterone receptors in breast cancer tissue, cleared by the FDA between 2002 and 2017; Dako is now part of Agilent."@en ;
  schema:url <https://onco.cc/drugs/dako-er-pr-ihc/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K042884>, <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K120663>, <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K130861>, <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K170028>, <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K170005>, <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K020023> ;
  onco:status "approved" ;
  onco:tag "test", "ihc-assay" ;
  onco:modality "Immunohistochemistry assay (oestrogen and progesterone receptor protein, breast tumour tissue)" ;
  onco:approval "US 2005: ER/PR pharmDx kit (510(k) K042884)", "US 2013: Oestrogen receptor alpha IHC, clone EP1 (510(k) K120663)", "US 2017: Dako Omnis ER EP1 (K170028) and PR PgR 1294 (K170005)" ;
  onco:related <https://onco.cc/biomarkers/er-status/>, <https://onco.cc/biomarkers/pr-status/>, <https://onco.cc/drugs/ventana-confirm-er-pr/>, <https://onco.cc/drugs/leica-er-pr-ihc/>, <https://onco.cc/collections/fda-device-databases/> ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:targets <https://onco.cc/targets/estrogen-receptor/>, <https://onco.cc/targets/pgr/> ;
  onco:companies <https://onco.cc/companies/agilent/> ;
  onco:terms <https://onco.cc/terms/ihc/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-asco-cap-er-pr-testing-guideline-jco-2010/> .